Publication: 3729

Publication: 3729

Randomized Phase II/III trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed glioblastoma (GBM) with MGMT promoter hypermethylation

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 40 (16_suppl) 2001-2001

Meeting Instance:: ASCO 2022
Year:: 2022
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 4256

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171, U10CA180868 (NRG); U10CA180888

Corr. Author:
Authors:: Jann N. Sarkaria Karla V. Ballman Sani H. Kizilbash Erik P. Sulman Caterina Giannini Bret Friday Jesse G. Dixon Brian F. Kabat Nadia Laack Leland Hu Ben Ellingson S. Keith Anderson Evanthia Galanis

Networks:: ESSENTIA, LAPS-MN026, LAPS-TX035

Study: Alliance-A071102
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2/3

Keywords: